The Osteosarcoma Biobank in Peking University People's Hospital

Establishment of Osteosarcoma Biobank

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03362086

Enrollment

180

Registered

2017-12-05

Start date

2018-02-01

Completion date

2024-02-01

Last updated

2017-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Keywords

bone tumor osteosarcoma

Brief summary

Osteosarcoma is very rare bone tumor. The investigator set up the biobank to ensure the patients has the chance to participate in future research

Detailed description

Samples of blood and other stored material such as slides,frozen tissues and so on . Questionnaire information, including health history, growth and development, physical activity and family medical history information.

Interventions

None listed

Study design

Observational model

FAMILY_BASED

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma

Exclusion criteria

non-asian pulmonary metastasis

Design outcomes

Primary

Measure	Time frame	Description
Examine VEGFR-2 and PD-L1 gene expression osteosarcoma	3 years	To examine the VEGFR2 and programmed cell death ligand 1 (PD-L1) genes expression of the patients with osteosarcoma.And Analyze their differences.

Contacts

Primary ContactKuisheng Liu, phD

liukuisheng01@163.com+8601088324471

Outcome results